Cargando…
Alzheimer’s Disease and Its Potential Alternative Therapeutics
Alzheimer’s Disease (AD) is a chronic neurodegenerative disease that affects over 5 million individuals in the United States alone. Currently, there are only two kinds of pharmacological interventions available for symptomatic relief of AD; Acetyl Cholinesterase Inhibitors (AChEI) and N-methyl-D-asp...
Autores principales: | Kisby, Brent, Jarrell, Juliet T, Agar, M Enes, Cohen, David S, Rosin, Eric R, Cahill, Catherine M, Rogers, Jack T, Huang, Xudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777730/ https://www.ncbi.nlm.nih.gov/pubmed/31588368 http://dx.doi.org/10.4172/2161-0460.1000477 |
Ejemplares similares
-
Modulation of SPARC/Hevin Proteins in Alzheimer’s Disease Brain Injury
por: Strunz, Maximilian, et al.
Publicado: (2019) -
Network Medicine for Alzheimer’s Disease and Traditional Chinese Medicine
por: Jarrell, Juliet T., et al.
Publicado: (2018) -
Identification and Analysis of Alzheimer’s Candidate Genes by an Amplitude Deviation Algorithm
por: Pang, Chaoyang, et al.
Publicado: (2019) -
Deep learning and virtual drug screening
por: Carpenter, Kristy A, et al.
Publicado: (2018) -
Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson’s Disease and Potential Therapeutic Role of 5’ Untranslated Region-Directed Small Molecules
por: Cahill, Catherine M., et al.
Publicado: (2020)